Søgeresultater - Cecilia M. Fenoglio‐Preiser

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    The future of prognostic factors in outcome prediction for patients with cancer

    The future of prognostic factors in outcome prediction for patients with cancer af L P Fielding, Cecilia M. Fenoglio‐Preiser, Laurence S. Freedman

    Udgivet 1992
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential

    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential af S. Coverlizza, Mauro Risio, Andrea Ferrari, Cecilia M. Fenoglio‐Preiser, F. P. Rossini

    Udgivet 1989
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    American Joint Committee on Cancer prognostic factors consensus conference

    American Joint Committee on Cancer prognostic factors consensus conference af Carolyn C. Compton, Cecilia M. Fenoglio‐Preiser, Norman M. Pettigrew, L P Fielding

    Udgivet 2000
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    Serrated Polyps of the Large Intestine

    Serrated Polyps of the Large Intestine af Dale C. Snover, Jeremy R. Jass, Cecilia M. Fenoglio‐Preiser, Kenneth P. Batts

    Udgivet 2005
    Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  5. 5
    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps

    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps af Won Chul Lee, Alfred I. Neugut, Gail Garbowski, Kenneth A. Forde, Michael R. Treat, J. Ways, Cecilia M. Fenoglio‐Preiser

    Udgivet 1993
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer af Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression

    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression af Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 af Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese

    Udgivet 2006
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation af Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen

    Udgivet 2006
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... af Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: